Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms

por Gujar, S A, Clements, D, Dielschneider, R, Helson, E, Marcato, P, Lee, P W K
Publicado 2014

The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro

por Alain, T, Kim, M, Johnston, R N, Urbanski, S, Kossakowska, A E, Forsyth, P A, Lee, P W K
Publicado 2006

Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation

por Pan, D, Pan, L-Z, Hill, R, Marcato, P, Shmulevitz, M, Vassilev, L T, Lee, P W K
Publicado 2011

Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy

por Hill, R, Rabb, M, Madureira, P A, Clements, D, Gujar, S A, Waisman, D M, Giacomantonio, C A, Lee, P W K
Publicado 2013

Attenuated reovirus displays oncolysis with reduced host toxicity

por Kim, M, Garant, K A, zur Nieden, N I, Alain, T, Loken, S D, Urbanski, S J, Forsyth, P A, Rancourt, D E, Lee, P W K, Johnston, R N
Publicado 2011